Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema (NCT07012642)
🩺 Plain-English Summary (8th-Grade Level)
Lymphedema affects millions and currently lacks effective drug treatments, relying mainly on compression therapy. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown potential in managing obesity and diabetes, which can worsen lymphedema. Although anecdotal evidence suggests benefits of GLP-1 RAs for lymphedema patients, rigorous prospective studies are lacking. This study aims to evaluate the effectiveness of GLP-1 RAs in improving quality of life and clinical outcomes in lymphedema patients, thereby addressing a critical gap in literature and potentially offering a new treatment option.
Who can join: Review the eligibility criteria below.
Location: River Center — Red Bank, New Jersey
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- River Center — Red Bank, New Jersey
- 260 Old Hook Rd Suite 304 — Westwood, New Jersey
📞 Contact the Study Coordinator
Phone: (866) 266-2577
Email: gtruax@sycamoremm.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lymphedema
- PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema — Houston, Texas
- Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection — Ann Arbor, Michigan
- Evaluating Factors In Study Experiences of Lymphedema Patients — San Francisco, California
- A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management — Harrison, New York
- Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE) — Houston, Texas
- Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial. — Houston, Texas
Explore by condition: All Lymphedema clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.